The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IκB-α stimulated by tumour necrosis factor-α in cultured vascular smooth muscle cells  by Zhao, Yong et al.
AC
T
e
I
c
E
p
d
e
b
s
t
n
D
1
hrchives of Cardiovascular Disease (2013) 106, 4—11
Available  online  at
www.sciencedirect.com
LINICAL RESEARCH
he  effect  of  tissue  factor  pathway  inhibitor  on  the
xpression  of  monocyte  chemotactic  protein-3  and
B-  stimulated  by  tumour  necrosis  factor-  in
ultured  vascular  smooth  muscle  cells
ffet  de  l’inhibition  de  la  voie  du  facteur  tissulaire  sur  l’expression  de  la
rotéine-3  et  de  IkB-  chimiotactique  stimulé  par  le  TNF- dans  des  cultures
e  cellules  vasculaires  musculaires  lisses
Yong  Zhaoa,1,  Yu  Fub,1,  Jing  Huc,  Yue  Liub,
Xinhua  Yinb,∗
a Department  of  General  Surgery,  The  First  Afﬁliated  Hospital  of  Harbin  Medical  University,
Harbin, China
b Department  of  Cardiology,  The  First  Afﬁliated  Hospital  of  Harbin  Medical  University,
Harbin,  China
c Department  of  Oncology,  The  Third  Afﬁliated  Hospital  of  Harbin  Medical  University,  Harbin,
China
Received 8  May  2012;  received  in  revised  form  18  August  2012;  accepted  4  September  2012
Available  online  21  December  2012KEYWORDS
Gene  therapy;
IB-;
Summary
Background.  —  In  recent  years,  the  importance  of  inﬂammation  in  restenosis  has  been  rec-
ognized gradually.  When  vascular  injury  occurs,  NF-B,  which  controls  transcription  of  many
inﬂammatory  genes  in  restenosis  (such  as  monocyte  chemotactic  protein-3  [MCP-3]),  is
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xpressing TFPI; CASMC, coronary artery smooth muscle cell; DMEM, Dulbecco’s modiﬁed Eagle’s medium; ELISA, enzyme-linked immunosor-
ent assay; FBS, foetal bovine serum; MCP-3, monocyte chemotactic protein-3; mRNA, messenger ribonucleic acid; PBS, phosphate buffered
aline; PCR, polymerase chain reaction; PTCA, percutaneous transluminal coronary angioplasty; RNA, ribonucleic acid; rTFPI, recombinant
issue factor pathway inhibitor; TBST, tris buffered saline with Tween; TF, tissue factor; TFPI, tissue factor pathway inhibitor; TNF, tumour
ecrosis factor; VSMC, vascular smooth muscle cell.
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activated  by  IB  degradation,  leaving  the  NF-B dimer-free  to  translocate  to  the  nucleus  to
activate speciﬁc  target  genes.
Aims.  —  To  investigate  the  effect  of  tissue  factor  pathway  inhibitor  (TFPI)  on  MCP-3  expression
and IB-  degradation  stimulated  by  tumour  necrosis  factor  (TNF)-  in  vascular  smooth  mus-
cle cells  (VSMCs),  thus  further  elucidating  the  mechanism  of  the  inhibitory  effect  of  TFPI  on
restenosis.
Methods.  —  Dulbecco’s  modiﬁed  Eagle’s  medium  or  human  recombinant  adenoviruses  expressing
TFPI or  bacterial  -galactosidase  (LacZ)  were  used  to  infect  rat  aortic  VSMCs  in  vitro.  Enzyme-
linked immunosorbent  assays  were  used  to  detect  exogenous  TFPI  expression  and  reverse
transcription-polymerase  chain  reactions  were  used  to  detect  MCP-3  expression  after  TNF-
stimulation in  transfected  cells.  Western  blotting  and  immunoﬂuorescence  microscopy  were
used to  examine  IB- expression.
Results.  —  TFPI  protein  was  detected  in  the  TFPI  group  after  gene  transfer.  The  cells  were
stimulated  with  TNF-  for  6  hours  on  the  third  day  after  gene  transfer.  MCP-3  messenger  ribonu-
cleic acid  expression  was  lower  in  the  TFPI  group  than  in  the  LacZ  group  (P  <  0.05)  and  IB-
degradation  was  lower  in  the  TFPI  group  than  in  the  LacZ  group  in  the  cytoplasm  (P  <  0.05).
Conclusion.  —  TFPI  inhibited  MCP-3  expression  induced  by  TNF-;  this  effect  may  be  propagated
through the  NF-B pathway.  TFPI  gene  transfer  may  be  a  new  therapeutic  strategy  for  inhibiting
restenosis  in  clinical  situations.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Justiﬁcation.  — Récemment,  l’importance  de  l’inﬂammation  dans  la  genèse  de  la  resténose  a
été établie.  Lorsqu’une  atteinte  vasculaire  survient,  NF-KB,  qui  contrôle  la  transcription  de
nombreux  gènes  de  l’inﬂammation  dans  la  resténose  telle  que  la  protéine  3  (MCP-3),  chimio-
tactique monocytaire  est  activée  avec  la  dégradation  d’IK et  la  libération  du  dimère  NF-KB,
et une  translocation  nucléaire  qui  aboutit  à  une  activation  spéciﬁque  des  gènes  cibles.
Objectif.  —  Investiguer  l’effet  de  l’inhibition  de  la  voie  du  facteur  tissulaire  (TFPI)  sur
l’expression  de  MCP-3  et  la  dégradation  de  IKB- stimulée  par  le  TNF-  au  sein  des  cellules
musculaires  lisses  vasculaires  et  ce  aﬁn  de  déterminer  les  conséquences  de  l’inhibition  du  TFPI
sur la  resténose.
Méthode.  — Le  TFPI  humain  ou  l’adénovirus  recombinant  LacZ  ou  le  DNEM  ont  été  utilisés  pour
infecter les  cellules  musculaires  lisses  vasculaires  (aorte  de  rat)  in  vitro.  Le  test  d’Elisa  était
utilisé pour  détecter  l’expression  du  TFPI  exogène  et  la  technique  RT-PCR  a  été  utilisée  pour
détecter l’expression  de  MCP-3  après  stimulation  du  TNF- dans  des  cellules  transfectées.  Les
techniques  de  Western  Blot  et  la  microscopie  par  immunoﬂuorescence  ont  été  utilisées  pour
examiner  l’expression  de  IKB-.
Résultats.  —  La  protéine  TFPI  a  été  détectée  dans  le  groupe  TFPI  après  transfert  génique.  Les
cellules ont  été  stimulées  par  le  TNF-  pendant  six  heures,  et  à  j3  après  transfert  génique.
L’expression  du  MCP-3  ARNm  dans  le  groupe  TFPI  était  plus  bas  que  dans  le  groupe  LacZ  (p  <  0,05)
et la  dégradation  du  IKB-  dans  le  groupe  TFPI  était  plus  bas  que  dans  le  groupe  LacZ  dans  le
cytoplasme  (p  <  0,05).
Conclusion.  —  Le  TFPI  peut  donc  inhiber  l’expression  de  MCP-3  induite  par  le  TNF-  et  cet  effet
peut être  propagé  au  travers  de  la  voie  NF-KB.  Le  transfert  de  gène  TFPI  pourrait  être  une
nouvelle  stratégie  thérapeutique  pour  favoriser  l’inhibition  de  la  resténose  en  pratique  clinique.
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Introduction
Restenosis  after  percutaneous  transluminal  coronary  angio-
plasty  (PTCA)  and  stent  placement  is  closely  related  to
thrombosis,  neointimal  hyperplasia,  inﬂammation  and  vas-
cular  remodelling  [1].  Coagulation  and  thrombosis  are  the
initializing  phases  of  restenosis;  some  active  substances
generated  in  this  process  can  lead  to  the  formation  of  neoin-
tima  by  stimulating  vascular  smooth  muscle  cell  (VSMC)
migration  and  proliferation,  and  also  by  activating  an
inﬂammatory  response.  In  recent  years,  recognition  of  the
i
is  droits  réservés.
mportance  of  inﬂammation  in  restenosis  has  increased
radually.  From  animal  models  and  clinical  experiments,
esearchers  have  found  that  endothelial  injury,  platelet  and
eukocyte  interactions,  cell  chemotactic  effects  and  inﬂam-
atory  mediators  are  all  key  factors  in  the  inﬂammatory
esponse  after  PTCA  and  stenting.  A  method  that  prevents
his  inﬂammatory  response  may  provide  a  new  therapeutic
trategy  for  inhibiting  restenosis  in  clinical  situations.It  is  well  known  that  the  expressions  of  several  genes
nvolved  in  the  inﬂammatory  response  and  restenosis
s  regulated  at  the  transcriptional  level  by  NF-B. In
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alloon-injured  arteries,  NF-B was  found  to  be  activated.
he  classical  activation  of  the  NF-B pathway  can  be  initi-
ted  by  a  wide  range  of  extracellular  stimuli.  These  agents
an  activate  the  cells  and  mediate  phosphorylation  of  IB,
esulting  in  its  degradation  and  leaving  the  NF-kB  dimer-free
o  translocate  to  the  nucleus  to  regulate  many  target  genes,
uch  as  chemokines  (e.g.  monocyte  chemotactic  protein-
 [MCP-3]).  Recently,  MCP-3,  which  is  a  member  of  the
C  chemokine  group  that  includes  MCP-1  and  macrophage
nﬂammatory  proteins,  was  found  to  be  involved  in  the
athological  process  of  atherosclerosis  and  restenosis  after
ascular  injury  [2—4].
Tissue  factor  (TF)  is  the  only  initiator  of  coagulation
n  the  classic  extrinsic  pathway  [5].  Tissue  factor  pathway
nhibitor  (TFPI)  is  an  anticoagulant  protein  found  in  serum.
FPI  inhibits  factor  Xa  and  the  TF/VIIa  complex  through  the
ormation  of  TFPI/FXa/FVIIa/TF,  regulates  TF  activity  and
xerts  anticoagulant  and  antithrombotic  effects.  Work  by
ur  group  and  others  has  demonstrated  that  TFPI  gene  trans-
er  or  recombinant  TFPI  (rTFPI)  irrigation  can  signiﬁcantly
educe  restenosis  by  inhibiting  thrombosis  and  neointimal
yperplasia  in  balloon-injured  arteries  [6—9]. Many  in  vitro
xperiments  have  indicated  that  TFPI  can  induce  VSMC
poptosis,  inhibit  VSMC  migration  and  thereby  reduce  the
ormation  of  neointima  [10,11].  At  the  present  time,  lit-
le  is  known  about  the  effect  of  TFPI  on  inﬂammation.  In
his  study,  we  transferred  the  TFPI  gene,  mediated  by  an
denovirus,  into  VSMCs  cultured  in  vitro.  The  VSMCs  were
hen  stimulated  with  tumour  necrosis  factor  (TNF)- and  we
xamined  the  effect  of  TFPI  on  the  expression  of  MCP-3  to
urther  investigate  the  anti-inﬂammatory  effect  of  TFPI.  To
eﬁne  the  anti-inﬂammatory  mechanism  of  TFPI,  we  also
nvestigated  the  effect  of  TFPI  on  the  degradation  of  IB-
ecause  it  is  known  that  expression  of  MCP-3  is  regulated  by
he  NF-B pathway.
ethods
eagents
he  recombinant  rat  TNF- was  purchased  from  Pepro-
ech  Technologies,  Rocky  Hill,  NJ,  USA.  The  enzyme-linked
mmunosorbent  assay  (ELISA)  kit  for  human  TFPI  protein  was
urchased  from  American  Diagnostica,  Inc.,  Stamford,  CT,
SA.  The  anti--actin  and  anti-IB-  antibodies  were  pur-
hased  from  Santa  Cruz  Biotechnology,  Inc.,  Santa  Cruz,  CA,
SA.  The  reverse  transcription-polymerase  chain  reaction
it  was  purchased  from  Promega,  Madison,  WI,  USA.  The  ade-
oviruses  containing  the  human  TFPI  gene  (Ad-TFPI)  and  the
acZ  gene  (Ad-LacZ)  (both  5  ×  108 pfu/mL)  were  obtained
rom  Dr.  Yin  Xinhua.
ell culture
at  VSMCs  were  isolated  from  the  media  of  the  thoracic
orta  of  male  Wistar  rats  (170—200  g)  and  were  cultured  in
ulbecco’s  modiﬁed  Eagle’s  medium  (DMEM;  Hyclone,  Cram-
ington,  UK)  supplemented  with  10%  foetal  bovine  serum
FBS).  VSMCs  were  allowed  to  grow  out  from  the  tissue,
hich  was  consequently  removed.  After  conﬂuence  was
5

5
aY.  Zhao  et  al.
eached,  cells  were  harvested  by  trypsinase.  Cells  between
assages  3  and  6  were  used  in  the  experiments.
denovirus infection
he  VSMCs  were  grown  in  six-well  plates  using  DMEM  con-
aining  10%  FBS.  When  70  to  80%  conﬂuence  was  reached,
he  cells  were  serum-deprived  for  24  hours.  Ad-TFPI  or  Ad-
acZ  was  added  to  the  medium  at  a  multiplicity  of  infection
f  100.  Two  hours  later,  the  cells  were  washed  three  times
ith  phosphate  buffered  saline  (PBS),  and  the  medium  was
hanged  to  DMEM  containing  10%  FBS.  As  a  control  in  all
xperiments,  an  identical  group  of  cells  was  left  uninfected
ut  was  incubated  for  2  hours  in  serum-free  DMEM.
nzyme-linked immunosorbent assay
ell  culture  media  from  each  group  (n  =  5)  were  collected,
espectively,  at  the  ﬁrst,  third,  ﬁfth  and  seventh  days  after
ene  transfer.  Quantitative  determination  of  TFPI  expres-
ion  was  performed  using  a  speciﬁc  ELISA  kit  for  human  TFPI
rotein  (American  Diagnostica,  Inc.),  following  the  manu-
acturer’s  instructions.
timulation immediately after gene transfer
mmediately  after  gene  transfer,  some  VSMCs  were  stimu-
ated  with  TNF- (10 ng/mL)  for  6  hours  and  the  medium
as  then  changed  to  DMEM  containing  10%  FBS.  The  VSMCs
hat  were  not  stimulated  with  TNF- were  considered  to  be
he  control  group.  On  the  third  day,  approximately  5  × 106
ells  were  washed  with  PBS  for  detection.
timulation 3 days after gene transfer
n  the  third  day  after  gene  transfer,  some  VSMCs  were  stim-
lated  with  TNF- (10  ng/mL)  for  6  hours  and  were  then
ashed  with  PBS  for  detection.  The  VSMCs  that  were  not
timulated  with  TNF- were  considered  as  the  control  group.
xpression of MCP-3 messenger ribonucleic
cid (mRNA)
n  the  third  day  after  gene  transfer,  approximately  5  ×  106
ells  in  each  group  (both  those  stimulated  immediately
nd  3  days  after  gene  transfer)  were  washed  with  PBS  in
reparation  for  extraction  of  the  total  cellular  ribonucleic
cid  (RNA)  (each  group,  n  =  6).  The  cells  were  then  resus-
ended  in  1  mL  Trizol  (Invitrogen,  Carlsbad,  CA,  USA),  and
he  total  RNA  in  each  group  was  extracted  according  to  the
anufacturer’s  guidelines  [10]. Reverse  transcription  was
erformed  with  1  g  of  isolated  RNA  using  a  reverse  tran-
cription  kit  (Promega).  The  reverse  transcription  reaction
as  carried  out  with  random  primers  according  to  the  man-
facturer’s  protocol.  The  complementary  DNA  (1  g)  was
mpliﬁed  using  gene-speciﬁc  primers.  The  following  primers
ere  designed  to  detect  rat  MCP-3  mRNA  levels  in  each
roup  (forward:  5′-CATGGAAGTCTGTGCTGAAG-3′;  reverse:
′-TGAAACTTCAGTAGTCATACA-3′;  494  base  pairs)  and  rat
-actin  (forward:  5′-GGCTACAGCTTCACCACCAC-3′;  reverse:
′-GCTTGC  TGATCCACATCTGC-3′;  499  base  pairs).  The  PCR
mpliﬁcation  cycles  for  the  MCP-3  mRNA  were  performed
on  
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as  follows:  94 ◦C  for  3  minutes;  94 ◦C  for  30  seconds,  54 ◦C
for  30  seconds,  72 ◦C  for  1  minute  for  30  cycles;  72 ◦C  for
5  minutes.  The  PCR  product  was  electrophoresed  using  a
1.5%  agarose  gel.  The  relative  band  intensities  were  mea-
sured  using  the  Global  Imaging  Systems,  Inc.,  Tampa,  FL,
USA  (GIS)  detection  system.  The  expression  levels  of  MCP-3
mRNA  were  expressed  as  the  relative  ratio  to  the  amount  of
-actin  mRNA  in  each  group.
Western blotting
On  the  third  day  after  gene  transfer,  VSMCs  were  stimulated
using  TNF- (10  ng/mL)  for  6  hours  (each  group,  n  =  6).  The
cells  were  then  washed  with  PBS  and  resuspended  in  cold
lysis  buffer  with  phenylmethanesulfonyl  ﬂuoride.  The  cell
lysate  was  incubated  on  ice  for  30  minutes  and  centrifuged
at  12000  g  for  15  minutes  at  4 ◦C.  The  protein  content  of  the
supernatant  was  determined  by  using  a  bicinchoninic  acid
(BCA)-200  protein  assay  kit  (Beyotime,  Haimen,  Jiangsu,
China)  [10]. Equal  amounts  of  the  proteins  (50  g)  were
loaded  into  the  gel  and  separated  by  12%  sodium  dodecyl
sulphate  polyacrylamide  gel  electrophoresis.  The  resolved
proteins  were  transferred  to  polyvinylidene  ﬂuoride  mem-
branes.  After  blocking  with  5%  non-fat  milk  in  tris  buffered
saline  with  Tween  (TBST)  for  1  hour  at  37 ◦C,  the  blots  were
incubated  overnight  at  4 ◦C  with  a  primary  antibody  against
either  actin  (1:500  mouse  monoclonal)  or  IB- (1:200  rab-
bit  polyclonal)  diluted  in  blocking  buffer.  The  membrane  was
washed  with  TBST  and  probed  with  a  horseradish  peroxidase-
conjugated  secondary  antibody  for  1  hour  at  37 ◦C.  The
membrane  was  washed  three  times  in  TBST  and  treated  with
3,3’-diaminobenzidine  according  to  the  manufacturer’s  pro-
tocol.  The  protein-antibody  complexes  conjugated  with  the
secondary  antibody  were  visualized  using  the  Global  Imaging
Systems,  Inc.  (GIS  imaging  system).
Immunoﬂuorescence microscopy
VSMCs  were  grown  in  24-well  plates  in  DMEM  containing  10%
FBS  with  a  slide  placed  in  each  well.  Either  Ad-TFPI  or  Ad-
LacZ  was  transfected  into  the  VSMCs  as  described  above.  At
the  third  day  after  gene  transfer,  the  VSMCs  were  stimulated
with  TNF- (10  ng/mL)  for  6  hours  (each  group,  n  =  7).  The
cells  were  then  washed  three  times  with  PBS,  ﬁxed  with
paraformaldehyde  for  30  minutes  and  washed  three  more
times  with  PBS.  After  incubating  with  0.1%  Triton  X-100  for
30  minutes  and  washing,  the  cells  on  the  slides  were  incu-
bated  overnight  at  4 ◦C  with  a  primary  antibody  against  IB-
(1:50  rabbit  polyclonal)  in  a  humidiﬁed  chamber  and  were
then  rinsed  three  times  in  PBS,  incubated  with  goat  anti-
rabbit  IgG-ﬂuorescein  isothiocyanate-conjugated  antibody
diluted  1:50  in  PBS  for  30  minutes  and  rinsed  three  more
times  with  PBS.  Cell  immunoﬂuorescence  was  observed
under  microscopy.
Statistical analysis
All  of  the  experiments  were  repeated  at  least  ﬁve  times,
with  similar  patterns  of  results.  All  results  are  expressed  as
mean  ±  standard  deviation.  Analysis  of  variance  was  used  for
the  statistical  analysis  and  a  value  of  P  <  0.05  was  considered
statistically  signiﬁcant.
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issue factor pathway inhibitor expression
FPI  protein  was  detected  in  the  TFPI  group  on  the  ﬁrst,
hird,  ﬁfth  and  seventh  days  after  gene  transfer  (Table  1).
eak  expression  occurred  on  the  third  day.  This  result
emonstrated  that  the  exogenous  TFPI  gene  was  transferred
nto  the  VSMCs  and  successfully  expressed.
CP-3 mRNA expression in VSMCs in response
o TNF- stimulation immediately after gene
ransfer
n  the  third  day  after  gene  transfer,  the  levels  of  MCP-3
RNA  were  measured.  The  VSMCs  that  were  not  stimulated
ith  TNF- (10  ng/mL)  expressed  only  a very  low  level  of
CP-3  mRNA.  In  the  presence  of  TNF- immediately  after
ene  transfer,  the  expression  of  MCP-3  mRNA  was  markedly
ncreased.  However,  the  level  of  MCP-3  mRNA  in  the  TFPI
roup  on  the  third  day  after  gene  transfer  did  not  decrease
ompared  with  the  levels  in  the  Ad-LacZ  and  DMEM  groups
p  >  0.05,  Fig.  1).  These  results  indicated  that  TFPI  could
ot  inhibit  the  expression  of  MCP-3  stimulated  immedi-
tely  after  gene  transfer.  We  speculated  that  there  was  not
nough  effective  TFPI  protein  expressed  at  this  moment.
CP-3 mRNA expression in VSMCs in response
o TNF- stimulation 3 days after gene
ransfer
he  results  showed  that  the  expression  of  MCP-3  mRNA  was
arkedly  increased  after  stimulation  on  the  third  day  after
ene  transfer  and  that  the  level  of  MCP-3  mRNA  in  the  TFPI
roup  was  lower  than  the  levels  in  the  Ad-LacZ  and  DMEM
roups  (P  <  0.05;  Fig.  2).  These  results  indicated  that  TFPI
ould  inhibit  the  expression  of  MCP-3  that  was  stimulated
y  TNF- on the  third  day  after  gene  transfer.
ffect of  TFPI on the expression of IB- using
estern blotting in response to TNF-
timulation 3 days after gene transfer
he  data  indicated  that  the  levels  of  IB-  in  the  cytoplasms
f  cells  in  each  stimulated  group  were  markedly  decreased
fter  the  stimulation  compared  with  those  in  the  normal
ontrol  group  (P  <  0.05),  but  that  the  expression  of  the  IB-
rotein  in  the  TFPI  group  was  greater  than  that  in  the  LacZ
roup  (P  <  0.05;  Fig.  3).  These  results  indicated  that  TFPI
ight  be  capable  of  inhibiting  the  degradation  of  IB-.
ffect of  TFPI on the expression of IB- using
mmunoﬂuorescence microscopy in response
o TNF- stimulation 3 days after gene
ransferhe  results  showed  that  there  was  a  moderate-intensity
reen  ﬂuorescence  in  the  cytoplasm  of  the  VSMCs  with
o  TNF- stimulation  and  that  no  green  ﬂuorescence  was
ound  in  the  nucleus.  After  TNF- stimulation,  the  green
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Table  1  Tissue  factor  pathway  inhibitor  protein  expression  in  each  group.
Group  1st  day  3rd  day  5th  day  7th  day
Ad-TFPI  13.62  ±  0.81  14.82  ±  0.77  12.53  ±  0.46  11.08  ±  0.94
Ad-LacZ  ND  ND  ND  ND
DMEM ND  ND  ND  ND
Data are mean ± standard deviation; n = 5. Ad-LacZ: human recombinant adenovirus expressing bacterial -galactosidase; Ad-TFPI:
human recombinant adenovirus expressing tissue factor pathway inhibitor; DMEM: Dulbecco’s modiﬁed Eagle’s medium; ND: not
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edetectable.
uorescence  in  the  cytoplasm  of  cells  in  each  group  was
eakened  compared  with  in  the  normal  control  group,  which
ad  no  stimulation,  but  the  ﬂuorescence  intensity  in  the
FPI  group  was  slightly  stronger  than  that  in  the  LacZ  group
Fig.  4).  This  result  was  consistent  with  the  results  from  the
estern  blotting.
iscussion
TCA  and  stenting  have  been  the  most  common  methods
sed  to  treat  coronary  artery  disease  since  the  world’s  ﬁrst
ngioplasty  was  successfully  performed  in  1977.  Resteno-
is  is  still  a  limitation  of  interventional  therapy  after
ngioplasty  procedures  or  intracoronary  stenting.  The  mech-
nisms  of  restenosis  are  very  complex.  To  date,  many  animal
estenosis  models  have  been  established  to  explain  the
echanisms  of  restenosis  [12,13].  Increasing  evidence  has
ndicated  that  inﬂammation  plays  an  important  role  in  the
evelopment  of  restenosis.TFPI  is  an  endogenous  anticoagulant  protein  and  is
he  only  substance  known  to  regulate  the  TF-dependent
oagulation  pathway.  TFPI,  which  consists  of  three  Kunitz
omains,  inhibits  TF  activity  by  forming  a  quaternary
a
i
g
t
igure 1. Monocyte chemotactic protein-3 (MCP-3) messenger ribonuc
ifferent groups stimulated with tumour necrosis factor (TNF)-  immedia
f the MCP-3 polymerase chain reaction (PCR) products. B. Semiquantitat
le cells (VSMCs). Ad-LacZ: human recombinant adenovirus expressing b
xpressing tissue factor pathway inhibitor; DMEM: Dulbecco’s modiﬁed Eomplex  through  two  steps.  First,  the  Kunitz  II  domain
inds  to  factor  Xa  and  the  Kunitz  I  domain  then  binds
o  the  TF/FVIIa  complex.  Many  studies  have  shown  that
FPI  reduces  neointimal  hyperplasia  in  local  injured  arteries
y  inhibiting  VSMC  proliferation  and  migration  [14,15]  and
hereby  has  the  potential  for  wide  application  in  preventing
hrombosis  and  restenosis.  However,  the  effect  of  TFPI  on
nﬂammation  has  not  yet  been  investigated  in  detail;  only
wo  reports  currently  exist  regarding  this  topic.  Nakamura
t  al.  [16]  demonstrated  that  the  number  of  macrophages  in
he  intima  and  media  was  signiﬁcantly  decreased  by  irrigat-
ng  rTFPI  into  the  local  balloon-injured  arteries.  Kopp  et  al.
17]  transferred  Ad-TFPI  into  local  injured  rabbit  femoral
rteries  and  found  that  MCP-1  expression  in  the  neointi-
al  hyperplasia  was  markedly  decreased  in  the  TFPI-treated
rteries,  but  the  mechanism  was  not  clear.
VSMCs  play  a  key  role  in  the  intimal  hyperplasia  caused  by
nﬂammation.  After  endothelial  denudation,  VSMCs  can  be
nduced  to  generate  many  inﬂammatory  factors  (including
hemokines),  which  then  act  on  the  macrophages  and  VSMCs
gain  [18]. The  chemokines  that  play  an  important  role
n  leukocytic  chemoattraction  and  activation  belong  to  a
roup  of  proinﬂammatory  factors.  In  the  formation  of  neoin-
ima,  some  chemokines,  such  as  MCP-1,  are  upregulated,
leic acid (mRNA) expression on the third day after gene transfer in
tely after gene transfer (n = 6). A. Representative autoradiographs
ive data regarding MCP-3 mRNA expression in vascular smooth mus-
acterial -galactosidase; Ad-TFPI: human recombinant adenovirus
agle’s medium. *P < 0.05.
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Figure 2. Monocyte chemotactic protein-3 (MCP-3) messenger ribonucleic acid (mRNA) expression on the third day after gene transfer in
different groups stimulated with tumour necrosis factor (TNF)- 3 days after gene transfer (n = 6). A. Representative autoradiographs of the
MCP-3 polymerase chain reaction (PCR) products. B. Semiquantitative data regarding MCP-3 mRNA expression in vascular smooth muscle cells
(VSMCs). Ad-LacZ: human recombinant adenovirus expressing bacterial -galactosidase; Ad-TFPI: human recombinant adenovirus expressing
tissue factor pathway inhibitor; DMEM: Dulbecco’s modiﬁed Eagle’s medium. *P < 0.05.
Figure 3. Western blotting was used to determine the expression of the IB- protein in the cytoplasm of each group after stimulation
with tumour necrosis factor (TNF)-  at the third day after gene transfer (n = 6). A. Western blotting result of IB- protein expression. B.
: hum
thwa
i
e
o
p
(Semiquantitative data regarding IB- protein expression. Ad-LacZ
Ad-TFPI: human recombinant adenovirus expressing tissue factor pa
and  activate  and  induce  VSMC  proliferation,  migration  and
extracellular  matrix  secretion,  which  ultimately  leads  to
macrophage  accumulation  and  neointimal  hyperplasia.  MCP-
3  is  known  to  have  biological  functions  in  common  with
MCP-1  [19]. Wang  et  al.  [4]  found  that  stimulating  cultured
VSMCs  with  inﬂammatory  factors  could  induce  MCP-3  mRNA
expression.  In  vivo,  a  signiﬁcant  induction  of  MCP-3  mRNA  (a
41-fold  increase  compared  with  the  control)  was  observed
w
o
pan recombinant adenovirus expressing bacterial -galactosidase;
y inhibitor; DMEM: Dulbecco’s modiﬁed Eagle’s medium. *P < 0.05.
n  the  carotid  artery  6  hours  after  balloon  angioplasty.  The
xpression  tendency  of  MCP-3  was  in  accordance  with  that
f  MCP-1.  Maddaluno  et  al.  [20]  also  found  that  MCP-3  was
roduced  by  human  coronary  artery  smooth  muscle  cells
CASMCs)  and  directly  induced  CASMC  proliferation  in  vitro,
hich  suggests  a  potential  role  for  MCP-3  in  vascular  pathol-
gy.  These  results  indicate  that  these  two  CC  chemokines
lay  a  valuable  role  in  restenosis  after  vascular  injury.
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Figure 4. Effect of tissue factor pathway inhibitor (TFPI) on the expression of IB- after stimulation with tumour necrosis factor (TNF)-
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e days after gene transfer, by immunoﬂuorescence method (× 200
-galactosidase; Ad-TFPI: human recombinant adenovirus expressin
In  this  study,  we  transferred  the  TFPI  gene  into  VSMCs  cul-
ured  in  vitro  and  stimulated  cells  with  TNF- to  observe  the
ffect  of  TFPI  on  the  expression  of  inﬂammatory  factors.  The
esults  showed  that  after  stimulation  with  TNF- for  6  hours
t  the  third  day  after  gene  transfer,  the  MCP-3  mRNA  lev-
ls  in  the  TFPI,  LacZ  and  DMEM  groups  were  all  increased
ompared  with  those  in  the  normal  control  group  (each
 <  0.05);  however,  the  MCP-3  mRNA  level  was  signiﬁcantly
ower  in  the  TFPI  group  than  in  the  LacZ  and  DMEM  groups
P  <  0.05).  These  results  indicated  that  TFPI  could  inhibit  the
xpression  of  MCP-3  mRNA  stimulated  by  TNF-. Thus,  we
peculated  that  TFPI  might  prevent  macrophage  accumula-
ion  and  VSMC  migration  and  proliferation  by  inhibiting  the
roinﬂammatory  factor  MCP-3  and  therefore  inhibit  neoin-
imal  proliferation.
NF-B is  an  important  transcription  factor  that  partici-
ates  in  the  inﬂammatory  reaction.  Maruyama  et  al.  [21]
ound  that  thrombin  activates  the  thrombin  receptor  on
he  surface  of  VSMCs;  the  signal  from  thrombin/thrombin
eceptors  then  activates  NF-B and  results  in  inﬂammation.
harma  et  al.  [22]  showed  that  deletion  of  the  cytoplas-
ic  domain  of  TF  could  reduce  NF-B activation  induced  by
ndotoxin.  Therefore,  we  speculated  that  TFPI  might  reduce
he  production  of  thrombin  by  inhibiting  TF,  block  the  acti-
ation  of  the  NF-B pathway  and  exert  an  anti-inﬂammatory
ffect.  Using  Western  blotting  and  immunoﬂuorescence
echniques  in  this  research,  we  investigated  whether  TFPI
v
A
d 7). Ad-LacZ: human recombinant adenovirus expressing bacterial
I; DMEM: Dulbecco’s modiﬁed Eagle’s medium.
ould  inhibit  the  expression  of  inﬂammatory  factors  by
locking  the  NF-B  pathway.  The  data  indicated  that  TFPI
ould  inhibit  the  degradation  of  IB-  in  the  cytoplasm.
herefore,  it  is  preliminarily  presumed  that  TFPI  might  exert
n  anti-inﬂammatory  effect  by  blocking  the  activation  of
he  NF-B pathway;  this  should  be  demonstrated  in  detail  in
uture  studies.
In this  study,  we  also  stimulated  VSMCs  with  TNF- for
 hours  immediately  after  gene  transfer  and  changed  the
edium  to  DMEM  containing  10%  FBS.  On  the  third  day
fter  gene  transfer,  we  found  that  TFPI  could  not  inhibit
CP-3  mRNA  expression  using  this  stimulation  method.  We
ypothesized  that  not  enough  TFPI  protein  was  generated
ithin  6  hours  after  gene  transfer  to  inhibit  inﬂammatory
actors  induced  by  TNF-. A  large  quantity  of  stimulating
nd  inﬂammatory  factors  is  produced  in  a  short  period  after
alloon  injury;  however,  during  this  short  period  of  time,
he  TFPI  gene  transferred  into  the  artery  wall  could  not  be
ranslated  into  an  active  protein  in  time  to  exert  its  func-
ion.  Therefore,  as  we  previously  described  [23], the  use  of
FPI  gene  transfer  and  rTFPI  irrigation  at  the  same  time  in
he  injured  arteries  has  been  proved  to  be  a  better  method.
The  present  ﬁndings  showed  that  TFPI  could  inhibit  the
xpression  of  proinﬂammatory  factor  MCP-3  and  thus  pre-
ent  VSMC  proliferation  and  reduce  neointimal  thickening.
t  the  same  time,  we  found  that  TFPI  could  inhibit  the  degra-
ation  of  IB-  induced  by  TNF- in  the  cytoplasm,  and  we
on  
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[TFPI  on  monocyte  chemotactic  protein-3  and  IB-  expressi
presumed  that  TFPI  might  exert  an  anti-inﬂammatory  effect
by  blocking  the  activation  of  the  NF-B pathway.  Because
TFPI  can  regulate  numerous  pivotal  molecular  mechanisms
involved  in  neointimal  hyperplasia  and  restenosis,  such  as
cell  proliferation,  migration,  apoptosis  and  inﬂammation
[14,24,25], adenovirus-mediated  TFPI  gene  transfer  may
provide  an  effective  method  for  the  local  treatment  of
restenosis  and  other  vascular  proliferative  diseases.  As  TFPI
has  an  anti-inﬂammatory  effect,  it  may  also  be  useful  in  the
treatment  of  inﬂammatory  diseases  in  the  future.
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